| Quantitative EEG (QEEG) measures differentiate Parkinson's disease (PD) patients from healthy controls (HC) M Chaturvedi, F Hatz, U Gschwandtner, JG Bogaarts, A Meyer, P Fuhr, ... Frontiers in aging neuroscience 9, 3, 2017 | 71 | 2017 |
| Phase lag index and spectral power as QEEG features for identification of patients with mild cognitive impairment in Parkinson's disease M Chaturvedi, JG Bogaarts, VV Kozak, F Hatz, U Gschwandtner, A Meyer, ... Clinical Neurophysiology 130 (10), 1937-1944, 2019 | 38* | 2019 |
| Increase of EEG spectral theta power indicates higher risk of the development of severe cognitive decline in Parkinson’s disease after 3 years VV Cozac, M Chaturvedi, F Hatz, A Meyer, P Fuhr, U Gschwandtner Frontiers in aging neuroscience 8, 284, 2016 | 35 | 2016 |
| Fine motor function skills in patients with Parkinson disease with and without mild cognitive impairment P Dahdal, A Meyer, M Chaturvedi, K Nowak, AD Roesch, P Fuhr, ... Dementia and geriatric cognitive disorders 42 (3-4), 127-134, 2016 | 35 | 2016 |
| Correlation of visuospatial ability and EEG slowing in patients with Parkinson’s disease D Eichelberger, P Calabrese, A Meyer, M Chaturvedi, F Hatz, P Fuhr, ... Parkinson’s Disease 2017, 2017 | 16 | 2017 |
| P122. Alpha1/theta ratio from quantitative EEG (qEEG) as a reliable marker for mild cognitive impairment (MCI) in patients with Parkinson’s disease (PD) H Bousleiman, M Chaturvedi, U Gschwandtner, F Hatz, C Schindler, ... Clinical Neurophysiology 126 (8), e150-e151, 2015 | 13 | 2015 |
| opnMe. com: a digital initiative for sharing tools with the biomedical research community A Gollner, M Köster, P Nicklin, T Trieselmann, E Klein, J Vlach, C Heine, ... Nature Reviews Drug Discovery 21 (7), 475-476, 2022 | 11 | 2022 |
| Cognitive decline in Parkinson’s disease is associated with reduced complexity of EEG at baseline SM Keller, U Gschwandtner, A Meyer, M Chaturvedi, V Roth, P Fuhr Brain Communications 2 (2), fcaa207, 2020 | 10 | 2020 |
| Among early appearing non-motor signs of Parkinson’s disease, alteration of olfaction but not electroencephalographic spectrum correlates with motor function VV Cozac, B Auschra, M Chaturvedi, U Gschwandtner, F Hatz, A Meyer, ... Frontiers in neurology 8, 545, 2017 | 10 | 2017 |
| The verbal fluency decline after deep brain stimulation in Parkinson's disease: is there an influence of age? VV Cozac, N Schwarz, H Bousleiman, M Chaturvedi, MM Ehrensperger, ... Movement disorders clinical practice 3 (1), 48-52, 2016 | 4 | 2016 |
| Dynamic Functional Connectivity of EEG: From Identifying Fingerprints to Gender Differences to a General Blueprint for the Brain's Functional Organization U Gschwandtner, G Bogaarts, M Chaturvedi, F Hatz, A Meyer, P Fuhr, ... Frontiers in Neuroscience 15, 683633, 2021 | 3 | 2021 |
| F67. Distinguishing Parkinson’s Disease Dementia (PDD) patients from Parkinson’s Disease (PD) patients using EEG frequency and connectivity measures M Chaturvedi, J Bogaarts, F Hatz, U Gschwandtner, V Cozac, A Meyer, ... Clinical Neurophysiology 129, e92, 2018 | 3 | 2018 |
| Target 2035–an update on private sector contributions S Ackloo, AA Antolin, JM Bartolome, H Beck, A Bullock, UAK Betz, ... RSC Medicinal Chemistry 14 (6), 1002-1011, 2023 | 1 | 2023 |
| EEG Slowing and Axial Motor Impairment Are Independent Predictors of Cognitive Worsening in a Three-Year Cohort of Patients With Parkinson's Disease VV Kozak, M Chaturvedi, U Gschwandtner, F Hatz, A Meyer, V Roth, ... Frontiers in aging neuroscience 12, 171, 2020 | 1 | 2020 |
| P77. Prognosis of cognitive decline in Parkinsons disease: a combined marker of quantitative EEG and clinical variables improves prediction A Meyer, JG Bogaarts, V Cozac, M Chaturvedi, I Handabaka, F Hatz, ... Clinical Neurophysiology 129 (8), e98-e99, 2018 | 1 | 2018 |
| P30. A novel application of the Phase-lag-Index in functional connectivity research JG Bogaarts, M Chaturvedi, V Cozac, U Gschwandtner, M Hardmeier, ... Clinical Neurophysiology 129 (8), e79, 2018 | 1 | 2018 |
| ID 77–Confounding effect of age on verbal fluency after deep brain stimulation to the subthalamic nucleus (DBS-STN) in Parkinson’s disease V Cozac, N Schwarz, M Chaturvedi, H Bousleiman, F Hatz, E Taub, ... Clinical Neurophysiology 127 (3), e79-e80, 2016 | 1 | 2016 |
| Quality of life measured by PDQ39 and SEIQoL during anti-stress training for Parkinson's disease (PD) patients K Nowak, A Meyer, M Chaturvedi, A Hadinia, U Gschwandtner, P Fuhr Parkinsonism & Related Disorders 22, e71, 2016 | 1 | 2016 |
| Fine motor function skills in patients with Parkinson disease (PD) with and without mild cognitive impairment (MCI) P Dahdal, A Meyer, M Chaturvedi, K Nowak, AD Roesch, ... Parkinsonism & Related Disorders 22, e62, 2016 | 1 | 2016 |
| P136. Relation of EEG frequency and apathy in patients with Parkinson’s disease (PD) A Meyer, H Bousleiman, M Chaturvedi, F Hatz, K Nowak, R Zimmermann, ... Clinical Neurophysiology 126 (8), e155, 2015 | 1 | 2015 |
